glp-1 receptor agonists are contraindicated in for the Reduction of Atherosclerotic Cardiovascular Risk Patients With Type 2 Diabetes Frontiers | GLP-1 Receptor Agonists:

doi: 10.1007/s001250050779 61 KubotaAYamadaYHayamiTYasudaKSomeyaYIharaYet al

The rate correlates with the speed and magnitude of weight loss rather than the specific medication used

Gastrointestinal side effects, frequently observed across this drug class, pose additional challenges for adherence, particularly in populations with high vulnerability to treatment dropout

By addressing these critical issues, this review aims to provide insights into optimizing post-transplant care and improving outcomes of patient and liver allograft survival

Potential heart benefits A study originally published in the J ournal of Experimental and Therapeutic Medicine found that some GLP-1 medications may lower the risk of heart disease